The findings of high levels of IgA anti-β2GPI amongSudanese SLE patients as well as healthy controls compared to Swedes, together withthe striking change in IgA aPL occurrence when adjusting to national referenceranges, have not been described before in patients of African origin. This evidence concerns the gene CD79A and systemic lupus erythematosus.